Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial

by Jan Biegus, Biniyam Demissei, Douwe Postmus, Gad Cotter, Beth A. Davison, G. Michael Felker, Gerasimos Filippatos, Claudio Gimpelewicz, Barry Greenberg, Marco Metra, Thomas Severin, John R. Teerlink, Adriaan A. Voors, Piotr Ponikowski
Published 2019-12-01

Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM‐HF, INOVATE‐HF, and NECTAR‐HF

by Inder S. Anand, Marvin A. Konstam, Helmut U. Klein, Douglas L. Mann, Jeffrey L. Ardell, Douglas D. Gregory, Joseph M. Massaro, Imad Libbus, Lorenzo A. DiCarlo, John James E. Udelson, Javed Butler, John D. Parker, John R. Teerlink
Published 2020-02-01

Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes

by Jozef Bartunek, Andre Terzic, Beth A. Davison, Atta Behfar, Ricardo Sanz‐Ruiz, Wojciech Wojakowski, Warren Sherman, Guy R. Heyndrickx, Marco Metra, Gerasimos S. Filippatos, Scott A. Waldman, John R. Teerlink, Timothy D. Henry, Bernard J. Gersh, Roger Hajjar, Michal Tendera, Stefanie Senger, Gad Cotter, Thomas J. Povsic, William Wijns, for the CHART Program
Published 2020-12-01

Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

by Susan Graham, Siqin Ye, Min Qian, Alexandra R Sanford, Marco R Di Tullio, Ralph L Sacco, Douglas L Mann, Bruce Levin, Patrick M Pullicino, Ronald S Freudenberger, John R Teerlink, J P Mohr, Arthur J Labovitz, Gregory Y H Lip, Conrado J Estol, Dirk J Lok, Piotr Ponikowski, Stefan D Anker, John L P Thompson, Shunichi Homma, WARCEF Investigators
Published 2014-01-01